Effects of Natalizumab on Circulating B Cells, T Regulatory Cells and Natural Killer Cells

Abstract

Natalizumab reduces VLA-4 expression on all investigated immune cells, but changes were most marked for B cells. Further differential effects on immune cells may be relevant to opportunistic central nervous system infections during treatment with natalizumab.